KU Hematology & Medical Oncology Review 2019

 

KU Hematology & Medical Oncology Review 2019
W

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal Cancers: How Much Do We Know?

By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
313 views
August 23, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Gastrointestinal
14:39
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and …

Feat. R. Al-Rajabi
16:20
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best…

Feat. R. Al-Rajabi
19:12
KU Hematology & Medical Oncology Review 2019

Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy…

Feat. W. Sun
18:29
KU Hematology & Medical Oncology Review 2019

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal…

Feat. W. Sun